Vault-13

5AM Venture Management, LLC

SAN FRANCISCO, CA · CIK 1799883 · 13F filing filed 2022-05-16

SEC-registered investment adviser since 2021 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
San Francisco, CA (main office)United States United Statesabout 8
Boston, MAUnited States United States7
New York, NYUnited States United States3

US visa salary filings

Job titleFilingsMedianRange
Senior Research AnalystNew York, NY 1 $350,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: 5AM Venture Management, LLC.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$457.8m reported value -14.1% vs Q4 2021
19positions
83.7%in top 10
2 new 1 added 1 reduced 0 sold out vs Q4 2021

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PEAR THERAPEUTICS INC CLASS A COM CLASS A COM 18,631,771 $94.1m20.55% 20.55% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 18.6m, Q1 2022 18.6m
2 CINCOR PHARMA INC COM COM 4,337,646 $76.1m16.62% 16.62% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 4.3m
3 ENTRADA THERAPEUTICS INC COM TRDA TRDA 4,408,379 $41.4m9.04% 9.04% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 4.4m, Q1 2022 4.4m
4 VOR BIOPHARMA INC COM COM 6,361,723 $38.4m8.39% 8.39% UnchangedShares held: Q2 2021 6.7m, Q3 2021 6.7m, Q4 2021 6.4m, Q1 2022 6.4m
5 RALLYBIO CORP COM COM 3,980,724 $27.8m6.07% 6.07% ReducedShares held: Q2 2021 0, Q3 2021 4.2m, Q4 2021 4.2m, Q1 2022 4.0m -210.0k -210,000 -5.0%
6 ARVINAS INC COM ARVN ARVN 400,000 $26.9m5.88% 5.88% UnchangedShares held: Q2 2021 400.0k, Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k
7 SCPHARMACEUTICALS INC COM SCPH SCPH 3,831,474 $21.8m4.75% 4.75% UnchangedShares held: Q2 2021 3.8m, Q3 2021 3.8m, Q4 2021 3.8m, Q1 2022 3.8m
8 AKOUOS INC COM COM 4,135,784 $19.6m4.29% 4.29% UnchangedShares held: Q2 2021 4.1m, Q3 2021 4.1m, Q4 2021 4.1m, Q1 2022 4.1m
9 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 862,286 $18.9m4.13% 4.13% UnchangedShares held: Q2 2021 1.4m, Q3 2021 1.4m, Q4 2021 862.3k, Q1 2022 862.3k
10 IMPEL NEUROPHARMA INC COM COM 2,884,791 $18.4m4.01% 4.01% UnchangedShares held: Q2 2021 2.9m, Q3 2021 2.9m, Q4 2021 2.9m, Q1 2022 2.9m
11 IVERIC BIO INC COM OPHT OPHT 1,027,874 $17.3m3.78% 3.78% AddedShares held: Q2 2021 0, Q3 2021 770.0k, Q4 2021 643.2k, Q1 2022 1.0m +384.6k +384,626 59.8%
12 IDEAYA BIOSCIENCES INC COM IDYA IDYA 1,398,066 $15.6m3.42% 3.42% UnchangedShares held: Q2 2021 1.8m, Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.4m
13 HOMOLOGY MEDICINES INC COM FIXX FIXX 4,535,919 $13.8m3.01% 3.01% UnchangedShares held: Q2 2021 4.5m, Q3 2021 4.5m, Q4 2021 4.5m, Q1 2022 4.5m
14 AVIDITY BIOSCIENCES INC COM RNA RNA 390,555 $7.2m1.58% 1.58% UnchangedShares held: Q2 2021 0, Q3 2021 555.6k, Q4 2021 390.6k, Q1 2022 390.6k
15 JANUX THERAPEUTICS INC COM JANX JANX 446,266 $6.4m1.40% 1.40% UnchangedShares held: Q2 2021 446.3k, Q3 2021 446.3k, Q4 2021 446.3k, Q1 2022 446.3k
16 COGENT BIOSCIENCES INC COM COGT COGT 711,412 $5.3m1.16% 1.16% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 711.4k
17 CABALETTA BIO INC COM CABA CABA 2,064,263 $4.2m0.92% 0.92% UnchangedShares held: Q2 2021 3.0m, Q3 2021 2.4m, Q4 2021 2.1m, Q1 2022 2.1m
18 5 01 ACQUISITION CORP COM CL A COM CL A 365,126 $3.6m0.79% 0.79% UnchangedShares held: Q2 2021 365.1k, Q3 2021 365.1k, Q4 2021 365.1k, Q1 2022 365.1k
19 CIDARA THERAPEUTICS INC COM COM 1,134,511 $945.0k0.21% 0.21% UnchangedShares held: Q2 2021 2.0m, Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m